135 related articles for article (PubMed ID: 12946533)
1. Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
Polinko M; Riffel K; Song H; Lo MW
J Pharm Biomed Anal; 2003 Sep; 33(1):73-84. PubMed ID: 12946533
[TBL] [Abstract][Full Text] [Related]
2. An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
Ritter MA; Furtek CI; Lo MW
J Pharm Biomed Anal; 1997 Apr; 15(7):1021-9. PubMed ID: 9160270
[No Abstract] [Full Text] [Related]
3. Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
Farthing D; Sica D; Fakhry I; Pedro A; Gehr TW
J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):374-8. PubMed ID: 9518174
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standard.
Prasaja B; Sasongko L; Harahap Y; Hardiyanti ; Lusthom W; Grigg M
J Pharm Biomed Anal; 2009 Apr; 49(3):862-7. PubMed ID: 19217738
[TBL] [Abstract][Full Text] [Related]
5. HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
Soldner A; Spahn-Langguth H; Mutschler E
J Pharm Biomed Anal; 1998 Jan; 16(5):863-73. PubMed ID: 9535198
[TBL] [Abstract][Full Text] [Related]
6. Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
Iwasa T; Takano T; Hara K; Kamei T
J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):325-30. PubMed ID: 10595730
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
Furtek CI; Lo MW
J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
Liu D; Jiang J; Wang P; Feng S; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):743-8. PubMed ID: 20153270
[TBL] [Abstract][Full Text] [Related]
9. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.
Yeung PK; Jamieson A; Smith GJ; Fice D; Pollak PT
Int J Pharm; 2000 Aug; 204(1-2):17-22. PubMed ID: 11011981
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-format-based solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry.
Kolocouri F; Dotsikas Y; Apostolou C; Kousoulos C; Loukas YL
Anal Bioanal Chem; 2007 Jan; 387(2):593-601. PubMed ID: 17119933
[TBL] [Abstract][Full Text] [Related]
11. Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS/MS.
Shah HJ; Kundlik ML; Patel NK; Subbaiah G; Patel DM; Suhagia BN; Patel CN
J Sep Sci; 2009 Oct; 32(20):3388-94. PubMed ID: 19750501
[TBL] [Abstract][Full Text] [Related]
12. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.
del Rosario Brunetto M; Contreras Y; Clavijo S; Torres D; Delgado Y; Ovalles F; Ayala C; Gallignani M; Estela JM; Martin VC
J Pharm Biomed Anal; 2009 Sep; 50(2):194-9. PubMed ID: 19446420
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
Oh KS; Park SJ; Shinde DD; Shin JG; Kim DH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():56-64. PubMed ID: 22483397
[TBL] [Abstract][Full Text] [Related]
14. Influence of compound danshen tablet on the pharmacokinetics of losartan and its metabolite EXP3174 by liquid chromatography coupled with mass spectrometry.
Yuan Y; Zhang H; Ma W; Sun S; Wang B; Zhao L; Zhang G; Chai Y
Biomed Chromatogr; 2013 Sep; 27(9):1219-24. PubMed ID: 23722257
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
Liu AC; Zhao LX; Xing J; Liu T; Du FY; Lou HX
Biol Pharm Bull; 2012; 35(2):145-50. PubMed ID: 22293343
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry.
Qi W; Zhao Q; Jiang J; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():27-34. PubMed ID: 24036499
[TBL] [Abstract][Full Text] [Related]
17. Analysis of losartan and carvedilol in urine and plasma samples using a dispersive liquid-liquid microextraction isocratic HPLC-UV method.
Soltani S; Ramezani AM; Soltani N; Jouyban A
Bioanalysis; 2012 Dec; 4(23):2805-21. PubMed ID: 23216121
[TBL] [Abstract][Full Text] [Related]
18. Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes.
Dorado P; Machín E; de Andrés F; Naranjo ME; Peñas-Lledó EM; Llerena A;
Drug Metabol Drug Interact; 2012; 27(4):217-33. PubMed ID: 23093260
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
Wong PC; Christ DD; Wong YN; Lam GN
Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
Liu D; Hu P; Matsushima N; Li X; Li L; Jiang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):190-7. PubMed ID: 17602900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
